Loading…

Copper and oxidation of hemoglobin: a comparison of horse and human hemoglobins

Oxidation studies of hemoglobin by Cu(II) indicate that for horse hemoglobin, up to a Cu(II)/heme molar ratio of 0.5, all of the Cu(II) added is used to rapidly oxidize the heme. On the other hand, most of the Cu(II) added to human hemoglobin at low Cu(II)/heme molar ratios is unable to oxidize the...

Full description

Saved in:
Bibliographic Details
Published in:Biochemistry (Easton) 1976-11, Vol.15 (24), p.5337-5343
Main Authors: Rifkind, Joseph M, Lauer, Linda D, Chiang, Scott C, Li, Norman C
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a353t-19b55f0bca2b63aec33ecde819aadd5f83a514635ae9b4fe2243fb6fc4e6bfbe3
cites
container_end_page 5343
container_issue 24
container_start_page 5337
container_title Biochemistry (Easton)
container_volume 15
creator Rifkind, Joseph M
Lauer, Linda D
Chiang, Scott C
Li, Norman C
description Oxidation studies of hemoglobin by Cu(II) indicate that for horse hemoglobin, up to a Cu(II)/heme molar ratio of 0.5, all of the Cu(II) added is used to rapidly oxidize the heme. On the other hand, most of the Cu(II) added to human hemoglobin at low Cu(II)/heme molar ratios is unable to oxidize the heme. Only at Cu(II)/heme molar ratios greater than 0.5 does the amount of oxidation per added Cu(II) approach that of horse hemoglobin. At the same time, binding studies indicate that human hemoglobin has an additional binding site involving one copper for every two hemes, which has a higher copper affinity than the single horse hemoglobin binding site. The Cu(II) oxidation of human hemoglobin is explained utilizing this additional binding site by a mechanism where a transfer of electrons cannot occur between the heme and the Cu(II) bound to the high affinity human binding site. The electron transfer must involve the Cu(II) bound to the lower affinity human hemoglobin binding site, which is similar to the only horse hemoglobin site. The involvement of beta-2 histidine in the binding of this additional copper is indicated by a comparison of the amino acid sequences of various hemoglobins which possess the additional site, with the amino acid sequences of hemoglobins which do not possess the additional site. Zn(II), Hg(II), and N-ethylmaleimide (NEM) are found to decrease the Cu(II) oxidation of hemoglobin. The sulfhydryl reagents, Hg(II) and NEM, produce a very dramatic decrease in the rate of oxidation, which can only be explained by an effect on the rate for the actual transfer of electrons between the Cu(II) and the Fe(II). The effect of Zn(II) is much smaller and can, for the most part, be explained by the increased oxygen affinity, which affects the ligand dissociation process that must precede the electron transfer process.
doi_str_mv 10.1021/bi00669a021
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_83693109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>83693109</sourcerecordid><originalsourceid>FETCH-LOGICAL-a353t-19b55f0bca2b63aec33ecde819aadd5f83a514635ae9b4fe2243fb6fc4e6bfbe3</originalsourceid><addsrcrecordid>eNptkD1PwzAQhi3EVylMrAyZYEABO47dmg1VfIlKrUqYrXNypilNHOxGgn9PoBUwMN2dnufupJeQY0YvGE3YpSkplVJB12-RHhMJjVOlxDbp0Q7EiZJ0nxyEsOjGlA7SPbLLhoOEpT0yGbmmQR9BXUTuvSxgVbo6cjaaY-Vels6U9VUEUe6qBnwZNsz5gN8r87aC-o8bDsmOhWXAo03tk-fbm2x0H48ndw-j63EMXPBVzJQRwlKTQ2IkB8w5x7zAIVMARSHskINgqeQCUJnUYpKk3Bpp8xSlsQZ5n5yu7zbevbUYVroqQ47LJdTo2qCHXCrOqOrE87WYexeCR6sbX1bgPzSj-is9_Se9zj7ZnG1NhcWv-x1Xh-M1LsMK338o-FctB3wgdDZ90mqWPWbTbKZnnX-29iEPeuFaX3eZ_Pv4EzyThzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83693109</pqid></control><display><type>article</type><title>Copper and oxidation of hemoglobin: a comparison of horse and human hemoglobins</title><source>ACS CRKN Legacy Archives</source><creator>Rifkind, Joseph M ; Lauer, Linda D ; Chiang, Scott C ; Li, Norman C</creator><creatorcontrib>Rifkind, Joseph M ; Lauer, Linda D ; Chiang, Scott C ; Li, Norman C</creatorcontrib><description>Oxidation studies of hemoglobin by Cu(II) indicate that for horse hemoglobin, up to a Cu(II)/heme molar ratio of 0.5, all of the Cu(II) added is used to rapidly oxidize the heme. On the other hand, most of the Cu(II) added to human hemoglobin at low Cu(II)/heme molar ratios is unable to oxidize the heme. Only at Cu(II)/heme molar ratios greater than 0.5 does the amount of oxidation per added Cu(II) approach that of horse hemoglobin. At the same time, binding studies indicate that human hemoglobin has an additional binding site involving one copper for every two hemes, which has a higher copper affinity than the single horse hemoglobin binding site. The Cu(II) oxidation of human hemoglobin is explained utilizing this additional binding site by a mechanism where a transfer of electrons cannot occur between the heme and the Cu(II) bound to the high affinity human binding site. The electron transfer must involve the Cu(II) bound to the lower affinity human hemoglobin binding site, which is similar to the only horse hemoglobin site. The involvement of beta-2 histidine in the binding of this additional copper is indicated by a comparison of the amino acid sequences of various hemoglobins which possess the additional site, with the amino acid sequences of hemoglobins which do not possess the additional site. Zn(II), Hg(II), and N-ethylmaleimide (NEM) are found to decrease the Cu(II) oxidation of hemoglobin. The sulfhydryl reagents, Hg(II) and NEM, produce a very dramatic decrease in the rate of oxidation, which can only be explained by an effect on the rate for the actual transfer of electrons between the Cu(II) and the Fe(II). The effect of Zn(II) is much smaller and can, for the most part, be explained by the increased oxygen affinity, which affects the ligand dissociation process that must precede the electron transfer process.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi00669a021</identifier><identifier>PMID: 187214</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Binding Sites ; Carbon Monoxide - pharmacology ; Cattle ; Copper - metabolism ; Electron Spin Resonance Spectroscopy ; Ethylmaleimide - pharmacology ; Heme - analysis ; Hemoglobins - metabolism ; Horses - blood ; Humans ; Kinetics ; Mercury - pharmacology ; Oxidation-Reduction ; Oxygen Consumption ; Rabbits ; Sheep ; Zinc - pharmacology</subject><ispartof>Biochemistry (Easton), 1976-11, Vol.15 (24), p.5337-5343</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a353t-19b55f0bca2b63aec33ecde819aadd5f83a514635ae9b4fe2243fb6fc4e6bfbe3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi00669a021$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi00669a021$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27064,27924,27925,56766,56816</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/187214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rifkind, Joseph M</creatorcontrib><creatorcontrib>Lauer, Linda D</creatorcontrib><creatorcontrib>Chiang, Scott C</creatorcontrib><creatorcontrib>Li, Norman C</creatorcontrib><title>Copper and oxidation of hemoglobin: a comparison of horse and human hemoglobins</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>Oxidation studies of hemoglobin by Cu(II) indicate that for horse hemoglobin, up to a Cu(II)/heme molar ratio of 0.5, all of the Cu(II) added is used to rapidly oxidize the heme. On the other hand, most of the Cu(II) added to human hemoglobin at low Cu(II)/heme molar ratios is unable to oxidize the heme. Only at Cu(II)/heme molar ratios greater than 0.5 does the amount of oxidation per added Cu(II) approach that of horse hemoglobin. At the same time, binding studies indicate that human hemoglobin has an additional binding site involving one copper for every two hemes, which has a higher copper affinity than the single horse hemoglobin binding site. The Cu(II) oxidation of human hemoglobin is explained utilizing this additional binding site by a mechanism where a transfer of electrons cannot occur between the heme and the Cu(II) bound to the high affinity human binding site. The electron transfer must involve the Cu(II) bound to the lower affinity human hemoglobin binding site, which is similar to the only horse hemoglobin site. The involvement of beta-2 histidine in the binding of this additional copper is indicated by a comparison of the amino acid sequences of various hemoglobins which possess the additional site, with the amino acid sequences of hemoglobins which do not possess the additional site. Zn(II), Hg(II), and N-ethylmaleimide (NEM) are found to decrease the Cu(II) oxidation of hemoglobin. The sulfhydryl reagents, Hg(II) and NEM, produce a very dramatic decrease in the rate of oxidation, which can only be explained by an effect on the rate for the actual transfer of electrons between the Cu(II) and the Fe(II). The effect of Zn(II) is much smaller and can, for the most part, be explained by the increased oxygen affinity, which affects the ligand dissociation process that must precede the electron transfer process.</description><subject>Animals</subject><subject>Binding Sites</subject><subject>Carbon Monoxide - pharmacology</subject><subject>Cattle</subject><subject>Copper - metabolism</subject><subject>Electron Spin Resonance Spectroscopy</subject><subject>Ethylmaleimide - pharmacology</subject><subject>Heme - analysis</subject><subject>Hemoglobins - metabolism</subject><subject>Horses - blood</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Mercury - pharmacology</subject><subject>Oxidation-Reduction</subject><subject>Oxygen Consumption</subject><subject>Rabbits</subject><subject>Sheep</subject><subject>Zinc - pharmacology</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1976</creationdate><recordtype>article</recordtype><recordid>eNptkD1PwzAQhi3EVylMrAyZYEABO47dmg1VfIlKrUqYrXNypilNHOxGgn9PoBUwMN2dnufupJeQY0YvGE3YpSkplVJB12-RHhMJjVOlxDbp0Q7EiZJ0nxyEsOjGlA7SPbLLhoOEpT0yGbmmQR9BXUTuvSxgVbo6cjaaY-Vels6U9VUEUe6qBnwZNsz5gN8r87aC-o8bDsmOhWXAo03tk-fbm2x0H48ndw-j63EMXPBVzJQRwlKTQ2IkB8w5x7zAIVMARSHskINgqeQCUJnUYpKk3Bpp8xSlsQZ5n5yu7zbevbUYVroqQ47LJdTo2qCHXCrOqOrE87WYexeCR6sbX1bgPzSj-is9_Se9zj7ZnG1NhcWv-x1Xh-M1LsMK338o-FctB3wgdDZ90mqWPWbTbKZnnX-29iEPeuFaX3eZ_Pv4EzyThzA</recordid><startdate>19761101</startdate><enddate>19761101</enddate><creator>Rifkind, Joseph M</creator><creator>Lauer, Linda D</creator><creator>Chiang, Scott C</creator><creator>Li, Norman C</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19761101</creationdate><title>Copper and oxidation of hemoglobin: a comparison of horse and human hemoglobins</title><author>Rifkind, Joseph M ; Lauer, Linda D ; Chiang, Scott C ; Li, Norman C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a353t-19b55f0bca2b63aec33ecde819aadd5f83a514635ae9b4fe2243fb6fc4e6bfbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1976</creationdate><topic>Animals</topic><topic>Binding Sites</topic><topic>Carbon Monoxide - pharmacology</topic><topic>Cattle</topic><topic>Copper - metabolism</topic><topic>Electron Spin Resonance Spectroscopy</topic><topic>Ethylmaleimide - pharmacology</topic><topic>Heme - analysis</topic><topic>Hemoglobins - metabolism</topic><topic>Horses - blood</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Mercury - pharmacology</topic><topic>Oxidation-Reduction</topic><topic>Oxygen Consumption</topic><topic>Rabbits</topic><topic>Sheep</topic><topic>Zinc - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rifkind, Joseph M</creatorcontrib><creatorcontrib>Lauer, Linda D</creatorcontrib><creatorcontrib>Chiang, Scott C</creatorcontrib><creatorcontrib>Li, Norman C</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rifkind, Joseph M</au><au>Lauer, Linda D</au><au>Chiang, Scott C</au><au>Li, Norman C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Copper and oxidation of hemoglobin: a comparison of horse and human hemoglobins</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>1976-11-01</date><risdate>1976</risdate><volume>15</volume><issue>24</issue><spage>5337</spage><epage>5343</epage><pages>5337-5343</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>Oxidation studies of hemoglobin by Cu(II) indicate that for horse hemoglobin, up to a Cu(II)/heme molar ratio of 0.5, all of the Cu(II) added is used to rapidly oxidize the heme. On the other hand, most of the Cu(II) added to human hemoglobin at low Cu(II)/heme molar ratios is unable to oxidize the heme. Only at Cu(II)/heme molar ratios greater than 0.5 does the amount of oxidation per added Cu(II) approach that of horse hemoglobin. At the same time, binding studies indicate that human hemoglobin has an additional binding site involving one copper for every two hemes, which has a higher copper affinity than the single horse hemoglobin binding site. The Cu(II) oxidation of human hemoglobin is explained utilizing this additional binding site by a mechanism where a transfer of electrons cannot occur between the heme and the Cu(II) bound to the high affinity human binding site. The electron transfer must involve the Cu(II) bound to the lower affinity human hemoglobin binding site, which is similar to the only horse hemoglobin site. The involvement of beta-2 histidine in the binding of this additional copper is indicated by a comparison of the amino acid sequences of various hemoglobins which possess the additional site, with the amino acid sequences of hemoglobins which do not possess the additional site. Zn(II), Hg(II), and N-ethylmaleimide (NEM) are found to decrease the Cu(II) oxidation of hemoglobin. The sulfhydryl reagents, Hg(II) and NEM, produce a very dramatic decrease in the rate of oxidation, which can only be explained by an effect on the rate for the actual transfer of electrons between the Cu(II) and the Fe(II). The effect of Zn(II) is much smaller and can, for the most part, be explained by the increased oxygen affinity, which affects the ligand dissociation process that must precede the electron transfer process.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>187214</pmid><doi>10.1021/bi00669a021</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 1976-11, Vol.15 (24), p.5337-5343
issn 0006-2960
1520-4995
language eng
recordid cdi_proquest_miscellaneous_83693109
source ACS CRKN Legacy Archives
subjects Animals
Binding Sites
Carbon Monoxide - pharmacology
Cattle
Copper - metabolism
Electron Spin Resonance Spectroscopy
Ethylmaleimide - pharmacology
Heme - analysis
Hemoglobins - metabolism
Horses - blood
Humans
Kinetics
Mercury - pharmacology
Oxidation-Reduction
Oxygen Consumption
Rabbits
Sheep
Zinc - pharmacology
title Copper and oxidation of hemoglobin: a comparison of horse and human hemoglobins
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A42%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Copper%20and%20oxidation%20of%20hemoglobin:%20a%20comparison%20of%20horse%20and%20human%20hemoglobins&rft.jtitle=Biochemistry%20(Easton)&rft.au=Rifkind,%20Joseph%20M&rft.date=1976-11-01&rft.volume=15&rft.issue=24&rft.spage=5337&rft.epage=5343&rft.pages=5337-5343&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi00669a021&rft_dat=%3Cproquest_cross%3E83693109%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a353t-19b55f0bca2b63aec33ecde819aadd5f83a514635ae9b4fe2243fb6fc4e6bfbe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=83693109&rft_id=info:pmid/187214&rfr_iscdi=true